New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Nutritional monitoring and education are vital to ensuring a well-balanced gluten-free diet

Nutritional monitoring and education are vital to ensuring a well-balanced gluten-free diet

by University of the Basque CountryGraphical abstract. Credit: DOI: 10.3390/nu13082877A review by the GLUTEN3S research group at the UPV/EHU-University of the Basque Country describes the nutriti
Gastroenterology March 28,2024
Nutritional monitoring and education are vital to ensuring a well-balanced gluten-free diet

Nutritional monitoring and education are vital to ensuring a well-balanced gluten-free diet

by University of the Basque CountryGraphical abstract. Credit: DOI: 10.3390/nu13082877A review by the GLUTEN3S research group at the UPV/EHU-University of the Basque Country describes the nutriti
Gastroenterology March 28,2024
Program may help patients with rheumatic diseases quit smoking

Program may help patients with rheumatic diseases quit smoking

by WileyCredit: CC0 Public DomainSmoking increases symptoms and health risks for patients with rheumatic diseases, but interventions to help patients quit are rarely available at rheumatology cli
Immunology & Rheumatology March 28,2024
Program may help patients with rheumatic diseases quit smoking

Program may help patients with rheumatic diseases quit smoking

by WileyCredit: CC0 Public DomainSmoking increases symptoms and health risks for patients with rheumatic diseases, but interventions to help patients quit are rarely available at rheumatology cli
Immunology & Rheumatology March 28,2024
Ultra-low dose rituximab controls disease activity for most rheumatoid arthritis patients in new study

Ultra-low dose rituximab controls disease activity for most rheumatoid arthritis patients in new study

by American College of RheumatologyCredit: CC0 Public DomainNew research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that in one study
Immunology & Rheumatology March 28,2024
Ultra-low dose rituximab controls disease activity for most rheumatoid arthritis patients in new study

Ultra-low dose rituximab controls disease activity for most rheumatoid arthritis patients in new study

by American College of RheumatologyCredit: CC0 Public DomainNew research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that in one study
Immunology & Rheumatology March 28,2024
Early combined treatment with biologic and conventional DMARDs could be effective for polyarticular juvenile arthritis

Early combined treatment with biologic and conventional DMARDs could be effective for polyarticular juvenile arthritis

by American College of RheumatologyCredit: CC0 Public DomainNew research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, found that patients sta
Immunology & Rheumatology March 28,2024
Early combined treatment with biologic and conventional DMARDs could be effective for polyarticular juvenile arthritis

Early combined treatment with biologic and conventional DMARDs could be effective for polyarticular juvenile arthritis

by American College of RheumatologyCredit: CC0 Public DomainNew research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, found that patients sta
Immunology & Rheumatology March 28,2024
Potential biomarker found for lung disease in scleroderma patients

Potential biomarker found for lung disease in scleroderma patients

by University of MichiganCredit: CC0 Public DomainResearchers have discovered a protein that may predict disease severity for a lung condition that often proves fatal to patients with scleroderma
Pulmonology March 28,2024
Potential biomarker found for lung disease in scleroderma patients

Potential biomarker found for lung disease in scleroderma patients

by University of MichiganCredit: CC0 Public DomainResearchers have discovered a protein that may predict disease severity for a lung condition that often proves fatal to patients with scleroderma
Pulmonology March 28,2024
Early drug intervention reduces risk of cardiovascular events in rheumatoid arthritis sufferers

Early drug intervention reduces risk of cardiovascular events in rheumatoid arthritis sufferers

by Rebecca Biason,University of TorontoCredit: CC0 Public DomainPeople who develop rheumatoid arthritis as older adults benefit from early and sustained use of a drug called Methotrexate (MTX),
Immunology & Rheumatology March 28,2024
Early drug intervention reduces risk of cardiovascular events in rheumatoid arthritis sufferers

Early drug intervention reduces risk of cardiovascular events in rheumatoid arthritis sufferers

by Rebecca Biason,University of TorontoCredit: CC0 Public DomainPeople who develop rheumatoid arthritis as older adults benefit from early and sustained use of a drug called Methotrexate (MTX),
Immunology & Rheumatology March 28,2024
Early RA treatment important for long-term outcomes

Early RA treatment important for long-term outcomes

(HealthDay)—Early treatment of rheumatoid arthritis (RA) is important for long-term outcomes, and there has been a decrease in mortality rates attributable to RA, according to two studies published on
Immunology & Rheumatology March 28,2024
Early RA treatment important for long-term outcomes

Early RA treatment important for long-term outcomes

(HealthDay)—Early treatment of rheumatoid arthritis (RA) is important for long-term outcomes, and there has been a decrease in mortality rates attributable to RA, according to two studies published on
Immunology & Rheumatology March 28,2024
Study paves way to better understanding, treatment of arthritis

Study paves way to better understanding, treatment of arthritis

by Steve Lundeberg,Oregon State UniversityWhole-joint images from mice in arthritis imaging study. Credit: Brian Bay, Oregon State UniversityOregon State University research has provided the fir
Immunology & Rheumatology March 28,2024
Study paves way to better understanding, treatment of arthritis

Study paves way to better understanding, treatment of arthritis

by Steve Lundeberg,Oregon State UniversityWhole-joint images from mice in arthritis imaging study. Credit: Brian Bay, Oregon State UniversityOregon State University research has provided the fir
Immunology & Rheumatology March 28,2024
Study upends understanding about joint injuries

Study upends understanding about joint injuries

by Cornell UniversityCredit: CC0 Public DomainAn injury to the anterior cruciate ligament (ACL) can lead to severe osteoarthritis in both animal and human patients. Now, a new interdisciplinary s
Immunology & Rheumatology March 28,2024
Study upends understanding about joint injuries

Study upends understanding about joint injuries

by Cornell UniversityCredit: CC0 Public DomainAn injury to the anterior cruciate ligament (ACL) can lead to severe osteoarthritis in both animal and human patients. Now, a new interdisciplinary s
Immunology & Rheumatology March 28,2024
Preterm birth more common in unvaccinated pregnant patients with rheumatic disease and COVID-19

Preterm birth more common in unvaccinated pregnant patients with rheumatic disease and COVID-19

by American College of RheumatologyCredit: Unsplash/CC0 Public DomainNew research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, found a g
Public Health & Prevention March 28,2024
Preterm birth more common in unvaccinated pregnant patients with rheumatic disease and COVID-19

Preterm birth more common in unvaccinated pregnant patients with rheumatic disease and COVID-19

by American College of RheumatologyCredit: Unsplash/CC0 Public DomainNew research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, found a g
Public Health & Prevention March 28,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com